CM
BIIB icon

Capula Management’s Biogen BIIB Stock Holding History

Capula Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,295
Closed -$3.75M – 1084
2025
Q4 		$3.75M Buy
21,295
+11,087
+109% +$1.81M 0.02% 165
2025
Q3 		$1.43M Buy
+10,208
New +$1.38M 0.01% 311
2023
Q3 		– Sell
-920
Closed -$262K – 516
2023
Q2 		$262K Buy
+920
New +$274K 0.01% 374
2023
Q1 		– Sell
-1,690
Closed -$468K – 707
2022
Q4 		$468K Buy
+1,690
New +$477K 0.01% 602
2021
Q4 		– Sell
-2,127
Closed -$602K – 252
2021
Q3 		$602K Buy
+2,127
New +$697K 0.01% 577

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capula Management's BIIB Position: Q1 2026 in Review

Capula Management sold out of Biogen (BIIB) in Q1 2026, closing a stake of 21,295 shares — an estimated $3.75M sold.

Capula Management first reported a position in BIIB in Q3 2021 and held it in 5 quarters. The position peaked at $3.75M in Q4 2025. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Capula Management reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Capula Management sold 21,295 Biogen shares in Q1 2026, an estimated $3.75M.
  • Capula Management first reported a position in Biogen in Q3 2021 and held it in 5 quarters.
  • Capula Management's Biogen position peaked at $3.75M in Q4 2025.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.